Connection

Nathan Dolloff to Multiple Myeloma

Back to Details
This is a "connection" page, showing publications Nathan Dolloff has written about Multiple Myeloma.
Nathan Dolloff
Connection Strength
3.781
Multiple Myeloma
  1. PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma. Cancer Chemother Pharmacol. 2022 05; 89(5):643-653.
    View in: PubMed
    Score: 0.722
  2. Discovery platform for inhibitors of IgH gene enhancer activity. Cancer Biol Ther. 2019; 20(4):571-581.
    View in: PubMed
    Score: 0.572
  3. Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma. Leukemia. 2019 04; 33(4):1011-1022.
    View in: PubMed
    Score: 0.568
  4. High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma. Leukemia. 2014 Nov; 28(11):2263-7.
    View in: PubMed
    Score: 0.422
  5. Targeted therapy of multiple myeloma. Adv Exp Med Biol. 2013; 779:197-221.
    View in: PubMed
    Score: 0.380
  6. Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9. Mol Cancer Ther. 2012 Nov; 11(11):2321-30.
    View in: PubMed
    Score: 0.372
  7. Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivo. Leuk Res. 2020 01; 88:106271.
    View in: PubMed
    Score: 0.153
  8. Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells. Oncotarget. 2017 May 30; 8(22):35863-35876.
    View in: PubMed
    Score: 0.129
  9. Emerging Therapeutic Strategies for Overcoming Proteasome Inhibitor Resistance. Adv Cancer Res. 2015; 127:191-226.
    View in: PubMed
    Score: 0.111
  10. Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model. Mol Cancer Ther. 2013 Jun; 12(6):1140-50.
    View in: PubMed
    Score: 0.097
  11. Effect of time to infusion of autologous stem cells (24 vs. 48?h) after high-dose melphalan in patients with multiple myeloma. Eur J Haematol. 2012 Aug; 89(2):145-50.
    View in: PubMed
    Score: 0.091
  12. Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma. Clin Lymphoma Myeloma Leuk. 2010 Dec; 10(6):464-8.
    View in: PubMed
    Score: 0.082
  13. Prozone effect of serum IgE levels in a case of plasma cell leukemia. J Hematol Oncol. 2010 Sep 10; 3:32.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.